New York, NY (June 1, 2006) Heller Ehrman LLP today announced the addition of Blaine E. Templeman as a shareholder in the firm’s New York office. Mr. Templeman joins Heller Ehrman from the New York office of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo P.C., where his practice focused on assisting clients with intellectual property development, biotech and technology licensing and collaborations; clinical trial documentation and management; and biotech technology mergers and acquisitions. Since the beginning of 2006, Heller Ehrman has added eight senior lawyers (including Mr. Templeman) to the firm’s New York office: Robert Buehler, former Chief of the Organized Crime & Terrorism Unit with the U.S. Attorney’s office for the Southern District of New York; Russell Reid, former Akin Gump bankruptcy partner; Henry Liu, former General Counsel and a Director-General at the China Securities Regulatory Commission; Kenneth Kirschner, James R. Hays and Jonathan Stoler, former chair and partners, respectively, of Kelley Drye’s Labor and Employment Practice Group; and Wesley Fredericks, Chair of the American Bar Association International Business Law Committee.
“We have a very strong and active life sciences practice nationally and over the last few years we have been steadily building our life sciences practice on the East Coast,” said Joseph T. McLaughlin, Chairman of Heller Ehrman’s New York office. “We also have one of the top IP practices in the country, so Blaine’s combined IP transaction and significant life sciences experience is an ideal fit for us. Heller Ehrman is focused on growing our New York and Washington, D.C. offices, and Blaine is a great addition to our corporate practice.”
Blaine E. Templeman
Prior to joining Heller Ehrman, Mr. Templeman was a partner at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo P.C. Mr. Templeman regularly provides counsel to a variety of drug discovery, development and pharmaceutical companies assisting with license agreements, collaborations, copromotion agreements, joint ventures, manufacturing and supply agreements, clinical study protocols, materials transfer agreements, clinical trial agreements and patient informed consents. He also provides counsel to clients with respect to technology M&A and asset sale transactions. Mr. Templeman earned his undergraduate degree from Oral Roberts University, summa cum laude, and his J.D. from New York University Law School, where he was an executive editorial board member for the Journal of International Law and Politics. Prior to attending law school, he was a Masters of Divinity candidate at Princeton Theological Seminary.
“Heller Ehrman has made its mark in New York and I am very proud to join such an outstanding group of attorneys,” said Mr. Templeman. “The opportunity to help build a premier IP transaction practice on the East Coast, while continuing to grow my clinical contracting practice, was very appealing and I’m looking forward to working with the firm’s successful IP practice.”
Intellectual Property Transactions Practice Group
Heller Ehrman’s Intellectual Property Transactions Practice Group has more than 45 attorneys with experience in strategic intellectual property transactions, licensing collaborations and alliances. Working closely with the firm’s patent professionals and scientific advisors (many of who hold PhDs and other advanced degrees), our IP Transactions Practice Group handles all aspects of domestic and global technology-related matters, including the commercialization of IP, the procurement of technology, data or tools, as well as manufacturing and business process outsourcing. We represent IP transactions clients in a range of industries, including life sciences, information technology, semiconductor, telecom, wireless, electronics, healthcare, entertainment and publishing.
Life Sciences Practice
Heller Ehrman has one of the largest and most comprehensive life sciences practices in the United States. For more than 40 years, the firm has played a pivotal role in the growth and development of innovative life sciences companies. In addition, we work extensively with the private and public financing communities on leading life sciences deals, including representation of major funds investing in the life sciences.
We provide legal guidance in all aspects of business and intellectual property strategy and development. We counsel companies on corporate and securities law at each stage of development. Our regulatory attorneys guide clients through their dealings with the FDA and other administrative agencies. We assist clients in all types of collaborations, technology transfer transactions, and mergers and acquisitions. Our industry-experienced litigators vigorously protect and defend patents, trademarks and other intellectual property.
Heller Ehrman’s New York office has 115 attorneys and recently moved into new offices in the landmark Times Square Tower. Clients represented by attorneys in the New York office include financial institutions, professional service firms and Fortune 500 companies, including VISA U.S.A, Ernst & Young LLP, Deloitte & Touche LLP, KPMG, PricewaterhouseCoopers, Citibank, JP Morgan Chase, Bank of America, Philip Morris USA, Washington Mutual, GMAC Commercial Mortgage Corp., Credit Suisse Securities, Goldman Sachs and Allen & Company, LLC.
Heller Ehrman LLP has more than 700 attorneys and professionals in 12 offices worldwide – Anchorage; Beijing; Hong Kong; Los Angeles; Madison, WI; New York; San Diego; San Francisco; Seattle; Silicon Valley; Singapore; and Washington, D.C. As a full-service law firm, we represent a wide range of industry leaders, from entrepreneurial, technology-driven enterprises to established, multinational conglomerates. At Heller Ehrman, we take a multidisciplinary approach to the practice of law, drawing upon our legal, scientific and industry knowledge from across the firm to build the best legal teams for our clients. Through commitment to our core values of Excellence, People, Teamwork, Innovation, Community and One Firm, we offer clients unparalleled legal service. For more information, please visit www.helleherman.com.
